An Introduction to Proteoglycans and Their Localization

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 12, 2012, Pages 885-897

  Couchman, John R ^a   Pataki, Csilla A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

chondroitin; core protein; dermatan; glycosaminoglycan; heparan; hyaluronan; polysaccharide

Indexed keywords

AGGRECAN; AGRIN; CHONDROITIN ABC LYASE; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOSAMINOGLYCAN; HEPARANASE; KERATAN SULFATE; MESSENGER RNA; N ACETYLGALACTOSAMINE 4 SULFATASE; NEUROCAN; PERLECAN; PROTEOGLYCAN; SYNDECAN 1; THROMBOMODULIN; VERSICAN;

ARTICLE; BINDING KINETICS; BIOAVAILABILITY; CATALYSIS; CHROMOSOME ANALYSIS; DIABETIC NEPHROPATHY; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LUNG NON SMALL CELL CANCER; MUTATIONAL ANALYSIS; NERVE CELL PLASTICITY; NONHUMAN; OSTEOCHONDRITIS DISSECANS; PATHOGENESIS; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CONGENITAL DISORDER; DIABETES MELLITUS; FIBROSIS; GENETICS; HUMAN; METABOLISM; MUTATION; NEOPLASM; PHYSIOLOGY; REVIEW;

INVERTEBRATA; VERTEBRATA;

ANIMALS; CONGENITAL ABNORMALITIES; DIABETES MELLITUS; EMBRYONIC DEVELOPMENT; FIBROSIS; GLYCOSAMINOGLYCANS; HUMANS; MUTATION; NEOPLASMS; ORGAN SPECIFICITY; PROTEOGLYCANS;

EID: 84873029601     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412464638     Document Type: Article

References (115)

1. Afratis N,Gialeli C,Nikitovic D,Tsegenidis T,Karousou E,Theocharis A,Pavão MS,Tzanakakis GN,Karamanos NK.Glycosaminoglycans: key players in cancer biology and treatment.FEBS J. 2012;279:1177-1197.
2. Allegretta M,Filmus J.Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma.Anticancer Agents Med Chem. 2011;11:543-548.
3. Arikawa-Hirasawa E,Le AH,Nishino I,Ho NC,Francomano CA,Govindraj P,Hassell JR,Devaney JM,Spranger J,Stevenson RE, et al.Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.Am J Hum Genet. 2002;70:1368-1375.
4. Arikawa-Hirasawa E,Wilcox WR,Le AH,Sliverman N,Govindraj P,Hassell JR,Yamada Y.Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.Nat Genet. 2001;27:431-434.
5. Arvatz G,Shafat I,Levy-Adam F,Ilan N,Voldavsky I.The heparanase system and tumor metastasis: is heparanase the seed and soil?.Cancer Metastasis Rev. 2011;30:253-268.
6. Aspberg A.The different roles of aggrecan interaction domains.J Histochem Cytochem. 2012;60:987-996.
7. Baghy K,Iozzo RV,Kovalszky I.Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.J Histochem Cytochem. 2012;60:262-268.
8. Bernert B,Porsch H,Heldin P.Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).J Biol Chem. 2011;286:42349-42359.
9. Bernfield M,Götte M,Park PW,Reizes O,Fitzgerald ML,Lincecum J,Zako M.Functions of cell surface heparan sulfate proteoglycans.Ann Rev Biochem. 1999;68:729-777.
10. Biernacka A,Dobaczewski M,Frangogiannis NG.TGF-β signaling in fibrosis.Growth Factors. 2011;29:196-202.
11. Border WA,Noble NA,Yamamoto T,Harper JR,Yamaguchi Y,Pierschbacher MD,Ruoslahti E.Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.Nature. 1992;360:361-364.
12. Bourgignon LY,Gilad E,Peyrollier K.Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.J Biol Chem. 2007;282:19426-19441.
13. Brewton RG,Wright DW,Mayne R.Structural and functional comparison of type IX collagen-proteoglycan from chicken cartilage and vitreous humor.J Biol Chem. 1991;266:4752-4757.
14. Brown TA,Bouchard T,St John T,Wayner E,Carter WG.Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.J Cell Biol. 1991;113:207-221.
15. Bullock SL,Fletcher JM,Beddington RS,Wilson VA.Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase.Genes Dev. 1998;12:1894-1906.
16. Campos-Xavier AB,Martinet D,Bateman J,Belluoccio D,Rowley L,Tan TY,Baxová A,Gustavson KH,Borochowitz ZU,Innes AM, et al.Mutations in the heparan-sulfate proteoglycan glypican-6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.Am J Hum Genet. 2009;84:760-770.
17. Capurro MI,Xu P,Shi W,Li F,Jia A,Filmus J.Glypican-3 inhibits hedgehog signaling during development by competing with patched for hedgehog binding.Dev Cell. 2008;14:700-711.
18. Caterson B.Fell-Muir lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others.Int J Exp Pathol. 2012;93:1-10.
19. Chen L,Sanderson RD.Heparanase regulates levels of syndecan-1 in the nucleus.PLoS One. 2009;4:e4947.
20. Chuang CY,Lord MS,Melrose J,Rees MD,Knox SM,Freeman C,Iozzo RV,Whitelock JM.Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan.Biochemistry. 2010;49:5524-5532.
21. Cichon S,Mühleisen TW,Degenhardt FA,Mattheisen M,Miró X,Strohmaier J,Steffens M,Meesters C,Herms S,Weingarten M, et al.Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder.Am J Hum Genet. 2011;88:372-381.
22. Couchman JR.Syndecans: proteoglycan regulators of membrane microdomains?.Nat Rev Mol Cell Biol. 2003;4:926-937.
23. Couchman JR.Commercial antibodies: the good bad and really ugly.J Histochem Cytochem. 2009;57:7-8.
24. Couchman JR.Transmembrane signaling proteoglycans.Ann Rev Cell Dev Biol. 2010;26:89-114.
25. Couchman JR,Caterson B,Christner JE,Baker JR.Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues.Nature. 1984;307:650-652.
26. Danielson KG,Baribault H,Holmes DF,Graham H,Kadler KE,Iozzo RV.Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility.J Cell Biol. 1997;136:729-743.
27. Dasgupta U,Dixit BL,Rusch M,Selleck S,The I.Functional conservation of the human EXT1 tumor suppressor gene and its Drosophila homolog tout velu.Dev Genes Evol. 2007;217:555-561.
28. David G,Bai XM,van der Scheuren B,Cassiman JJ,van den Berghe H.Developmental changes in heparan sulfate expression: in situ detection with mAbs.J Cell Biol. 1992;119:961-975.
29. de la Motte CA,Drazba JA.Viewing hyaluronan: imaging contributes to imagining new roles for this amazing matrix polymer.J Histochem Cytochem. 2011;59:252-257.
30. Dick G,Akslen-Hoel LK,Grøndahl F,Kjos I,Prydz K.Proteoglycans synthesis and Golgi organization in polarized epithelial cells.J Histochem Cytochem. 2012;60:926-935.
31. Du WW,Yang BB,Shatseva TA,Yang BL,Deng Z,Shan SW,Lee DY,Seth A,Yee AJ.Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor.PLoS One. 2010;5:e13828.
32. Echtermeyer F,Streit M,Wilcox-Adelman S,Saoncella S,Denhez F,Detmar M,Goetinck P.Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.J Clin Invest. 2001;107:R9-R14.
33. Eriksson AS,Spillmann D.The mutual impact of syndecan-1 and its glycosaminoglycan chains: a multivariate puzzle.J Histochem Cytochem. 2012;60:936-942.
34. Filmus J,Capurro M.The role of glypican-3 in the regulation of body size and cancer.Cell Cycle. 2008;7:2787-2790.
35. Forsberg E,Pejler G,Ringvall M,Lunderius C,Tomasini-Johansson B,Kusche-Gullberg M,Eriksson I,Ledin J,Hellman L,Kjellén L.Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme.Nature. 1999;400:773-776.
36. Friedl A,Chang Z,Tierney A,Rapraeger AC.Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues.Am J Pathol. 1997;150:1443-1455.
37. Frischknecht R,Seidenbecher CI.Brevican: a key proteoglycan in the perisynaptic extracellular matrix of the brain.Int J Biochem Cell Biol. 2012;44:1051-1054.
38. Fu Y,Nagy JA,Brown LF,Shih S-C,Johnson PY,Chan CK,Dvorak HF,Wight TN.Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF induced pathological angiogenesis.J Histochem Cytochem. 2011;59:463-473.
39. Fux L,Ilan N,Sanderson RD,Voldavsky I.Heparanase: busy at the cell surface.Trends Biochem Sci. 2009;34:511-519.
40. Gallet A,Staccini-Lavenant L,Thérond PP.Cellular trafficking of the glypican Dally-like is required for full-strength hedgehog signaling and wingless transcytosis.Dev Cell. 2008;14:712-725.
41. Gil N,Goldberg R,Newman T,Garsen M,Zcharia E,Rubinstein AM,van Kuppevelt T,Meirovitz A,Pisano C,Li JP, et al.Heparanase is essential fort he development of diabetic nephropathy.Diabetes. 2012;61:208-216.
42. Habuchi H,Kimata K.Mice deficient in heparan sulfate 6-O-sulfotransferase 1.Prog Mol Biol Trans Sci. 2010;93:79-111.
43. Hascall VC,Majors AK,de la,Motte CA,Evanko SP,Wang A,Drazba JA,Strong SA,Wight TN.Intracellular hyaluronan: a new frontier for inflammation?.Biochim Biophys Acta. 2004;1673:3-12.
44. Hernández D,Miguel-Serra L,Docampo MJ,Marco-Ramell A,Cabrera J,Fabra A,Bassols A.V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.J Biol Chem. 2011;286:1475-1485.
45. Hienola A,Tumova S,Kulesskiy E,Rauvala H.N-syndecan deficiency impairs neural migration in brain.J Cell Biol. 2006;174:569-580.
46. Proteoglycan protocols. Iozzo RV, ed. Totowa, NJ: Humana; 2001:.
47. Iozzo RV,Zoeller JJ,Nystrom A.Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis.Mol Cells. 2009;27:503-513.
48. Jacobetz MA,Chan DS,Neesse A,Bapiro TE,Cook N,Frese KK,Feig C,Nakagawa T,Caldwell ME,Zecchini HI, et al.Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.Gut. 2012;:.
49. Jiang D,Liang J,Noble PW.Hyaluronan as an immune regulator in human diseases.Physiol Rev. 2011;91:221-264.
50. Khotskaya YB,Dai Y,Ritchie JP,MacLeod V,Yang Y,Zinn K,Sanderson RD.Syndecan-1 is required for robust growth, vascularisation and metastasis of myeloma tumors in vivo.J Biol Chem. 2009;284:26085-26095.
51. Kim JS,Werth VP.Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.J Histochem Cytochem. 2011;59:780-790.
52. Kim S,Takahashi H,Lin WW,Descargues P,Grivennikov S,Kim Y,Luo JL,Karin M.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.Nature. 2009;457:102-106.
53. Kim Y,Lee YS,Choe J,Lee H,Kim YM,Jeoung D.CD44-hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase and MMP-2.J Biol Chem. 2008;283:22513-22528.
54. Kolset SO,Reinholt FP,Jenssen T.Diabetic nephropathy and extracellular matrix.J Histochem Cytochem. 2012;60:975-986.
55. Koziel L,Kunath M,Kelly OG,Vortkamp A.Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification.Dev Cell. 2004;6:801-813.
56. Kreuger J,Kjellén L.Heparan sulfate biosynthesis: regulation and variability.J Histochem Cytochem. 2012;60:898-907.
57. Lemire JM,Braun KR,Maurel P,Kaplan ED,Schwartz SM,Wight TN.Versican/PG-M isoforms in vascular smooth muscle cells.Arterioscler Thromb Vasc Biol. 1999;19:1630-1639.
58. Lendorf ME,Manon-Jensen T,Kronqvist P,Multhaupt HAB,Couchman JR.Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma.J Histochem Cytochem. 2011;59:615-629.
59. Li JP,Gong F,Hagner-McWhirter A,Forsberg E,Abrink M,Kisilevsky R,Zhang X,Lindahl U.Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality.J Biol Chem. 2003;278:28363-28366.
60. Majumdar MK,Askew R,Schelling S,Stedman N,Blanchet T,Hopkins B,Morris EA,Glasson SS.Double knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis.Arth Rheum. 2007;56:3670-3674.
61. Malmström A,Bartolini B,Thelin MA,Pacheco B,Maccarana M.Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function.J Histochem Cytochem. 2012;60:916-925.
62. Manon-Jensen T,Itoh Y,Couchman JR.Proteoglycans in health and disease: the multiple roles of syndecan shedding.FEBS J. 2010;277:3876-3889.
63. Meen AJ,Øynebråten I,Reine TM,Duelli A,Svennevig K,Pejler G,Jenssen T,Kolset SO.Serglycan is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemoskine GROα/CXCL1.J Biol Chem. 2011;286:2636-2647.
64. Merline R,Moreth K,Beckmann J,Nastase MV,Zeng-Brouwers J,Tralhão JG,Lemarchand P,Pfeilschifter J,Schaefer RM,Iozzo RV, et al, et al.Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and microRNA-21.Sci Signal. 2011;4:ra75.
65. Misra S,Obeid LM,Hannun YA,Minamisawa S,Berger FG,Markwald RR,Toole BP,Ghatak S.Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.J Biol Chem. 2008;283:14335-14344.
66. Moreth K,Brodbeck R,Babelova A,Gretz N,Spieker T,Zeng-Brouwers J,Pfeilschifter J,Young MF,Schaefer RM,Schaefer L.The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL-13 and aggravates murine lupus nephritis.J Clin Invest. 2010;120:4251-4272.
67. Morgan MR,Humphries MJ,Bass MD.Synergistic control of cell adhesion by integrins and syndecans.Nat Rev Mol Cell Biol. 2007;8:957-969.
68. Muenzer J.Overview of the mucopolysaccharidoses.Rheumatology (Oxford). 2011;50:v4-12.
69. Multhaupt HAB,Couchman JR.Heparan sulfate biosynthesis: methods for investigation of the heparanosome.J Histochem Cytochem. 2012;60:908-915.
70. Murakami M,Simons M.Fibroblast growth factor regulation of neovascularisation.Curr Opin Hematol. 2008;15:215-220.
71. Nahmad M,Lander AD.Spatiotemporal mechanisms of morphogen gradient interpretation.Curr Opin Genet Dev. 2011;21:726-731.
72. Nastase MV,Young MF,Schaefer L.Biglycan: a multivalent proteoglycan providing structure and signals.J Histochem Cytochem. 2012;60:963-975.
73. Okamoto K,Tokunaga K,Doi K,Fujita T,Suzuki H,Katoh T,Watanabe T,Nishida N,Mabuchi A,Takahashi A, et al.Common variation in GPC5 is associated with acquired nephritic syndrome.Nat Genet. 2011;43:459-463.
74. Pellegrini L,Burke DF,von Delft F,Mulloy B,Blundell TL.Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.Nature. 2000;407:1029-1034.
75. Penttinen RP,Kobayashi S,Bornstein P.Transforming growth factor beta increases mRNA for matrix proteins in the presence and absence of changes in mRNA stability.Proc Natl Acad Sci U S A. 1988;85:1105-1108.
76. Ponta H,Sherman L,Herlich PA.CD44: from adhesion molecules to signaling receptors.Nat Rev Mol Cell Biol. 2003;4:33-45.
77. Puré E,Assoian RK.Rheostatic signaling by CD44 and hyaluronan.Cell Signal. 2009;21:651-655.
78. Rada JA,Cornuet PK,Hassell JR.Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycans (lumican and decorin) core proteins.Exp Eye Res. 1993;56:635-648.
79. Rah MJ.A review of hyaluronan and its ophthalmic applications.Optometry. 2011;82:38-43.
80. Rapraeger AC,Krufka A,Olwin BB.Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.Science. 1991;252:1705-1708.
81. Reed CC,Iozzo RV.The role of decorin in collagen fibrillogenesis and skin homeostasis.Glycoconj J. 2002;19:249-255.
82. Rhiner C,Gysi S,Frohli E,Henegartner MO,Hajnal A.Syndecan regulates cell migration and axon guidance in C. elegans.Development. 2005;132:4621-4633.
83. Ricciardelli C,Sakko AJ,Ween MP,Russell DL,Horsfall DJ.The biological role and regulation of versican levels in cancer.Cancer Metastasis Rev. 2009;28:233-245.
84. Richardson TP,Trinkaus-Randall V,Nugent MA.Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin.J Cell Sci. 2001;114:1613-1623.
85. Ringvall M,Ledin J,Holmborn K,van Kuppevelt T,Ellin F,Eriksson I,Olofsson AM,Kjellén L,Forsberg E.Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1.J Biol Chem. 2000;275:25926-25930.
86. Rönnberg E,Melo FR,Pejler G.Mast cell proteoglycans.J Histochem Cytochem. 2012;60:950-962.
87. Rosen SD,Lemjabbar-Alaoui H.Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.Expert Opin Ther Targets. 2010;14:935-949.
88. Saksela O,Moscatelli D,Sommer A,Rifkin DB.Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.J Cell Biol. 1988;107:743-751.
89. Sanderson RD,Iozzo RV.Targeting heparanase for cancer therapy at the tumor-matrix interface.Matrix Biol. 2012;31:283-284.
90. Sangaard KW,Sonne-Schmidt CS,Krogager TP,Lorentzen KA,Wisniewski HG,Thørgersen IB,Enghild JJ.The transfer of heavy chains from bikunin proteins to hyaluronan requires both TSG-6 and HC-2.J Biol Chem. 2008;283:18530-18537.
91. Saper CB.A guide to the perplexed on the specificity of antibodies.J Histochem Cytochem. 2009;57:1-5.
92. Schlessinger J,Plotnikov AN,Ibrahmi OA,Eliseenkova AV,Yeh BK,Yayon A,Linhardt RJ,Mohammadi M.Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.Mol Cell. 2000;6:743-750.
93. Shintani Y,Takashima S,Asano Y,Kato H,Liao Y,Yamazaki S,Tsukamoto O,Seguchi O,Yamamoto H,Fukushima T, et al.Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.EMBO J. 2006;25:3045-3055.
94. Siiskonen H,Törrönen K,Kumlin T,Rilla K,Tammi MI.Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.J Histochem Cytochem. 2011;59:908-917.
95. Smith RA,Meade K,Pickford CE,Holley RJ,Merry CL.Glycosaminoglycans as regulators of stem cell differentiation.Biochem Soc Trans. 2011;39:383-387.
96. Stanton H,Melrose J,Little CB,Fosang AJ.Proteoglycan degradation by the ADAMTS family of proteinases.Biochim Biophys Acta. 2011;1812:1616-1629.
97. Stattin EL,Wiklund F,Lindblom K,Onnerfjord P,Jonsson BA,Tegner Y,Sasaki T,Struglics A,Lohmander S,Dahl N, et al.A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans.Am J Hum Genet. 2010;86:126-137.
98. Subbaiah VK,Kranjec C,Thomas M,Banks L.PDZ domain: the building blocks regulating tumorigenesis.Biochem J. 2011;439:195-205.
99. Tamm C,Kjellén L,Li J-P.Heparan sulfate biosynthesis enzymes in embryonic stem cell biology.J Histochem Cytochem. 2012;60:943-949.
100. Tammi RH,Passi AG,Rilla K,Karousou E,Vignetti D,Makkonen K,Tammi MI.Transcriptional and post-translational regulation of hyaluronan synthesis.FEBS J. 2011;278:1419-1428.
101. Teng YH,Aquino RS,Park PW.Molecular functions of syndecan-1 in disease.Matrix Biol. 2012;31:3-16.
102. Traister A,Shi W,Filmus J.Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface.Biochem J. 2008;410:503-511.
103. Troeberg L,Nagase H.Proteases involved in cartilage matrix degradation in osteoarthritis.Biochim Biophys Acta. 2012;1824:133-145.
104. Thompson SM,Fernig DG,Jesudason EC,Losty PD,van de Westerlo EMA,van Kuppevelt TH,Turnbull JE.Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics.J Biol Chem. 2009;284:35621-35631.
105. Valayannopoulos V,Wijburg FA.Therapy for the mucopolysaccharidoses.Rheumatology (Oxford). 2011;50:v49-59.
106. van Kuppevelt TH,Dennissen MABA,van Venrooij WJ,Hoet RMA,Veerkamp JH.Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology.J Biol Chem. 1998;273:12960-12966.
107. Váradi T,Mersich T,Auvinen P,Tammi R,Tammi M,Salamon F,Besznyák I,Jakab F,Baranyai Z,Szöllo{double acute}si J, et al.Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.J Histochem Cytochem. 2012;60:567-575.
108. Wang A,Hascall VC.Hyperglycaemia, intracellular hyaluronan synthesis, cyclin D3 and autophagy.Autophagy. 2009;5:864-865.
109. Wang A,de al,Motte CA,Lauer M,Hascall VC.Hyaluronan matrices in pathobiological processes.FEBS J. 2011;278:1412-1418.
110. Wang Q,Teder P,Judd NP,Noble PW,Poerschuk CM.CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice.Am J Pathol. 2002;161:2219-2228.
111. Ween MP,Oehler MK,Ricciardelli C.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Int J Mol Sci. 2011;12:1009-1029.
112. Yamaguchi Y.Lecticans: organizers of the brain extracellular matrix.Cell Mol Life Sci. 2000;57:276-289.
113. Yoneda A,Lendorf ME,Couchman JR,Multhaupt HAB.Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.J Histochem Cytochem. 2012;60:9-21.
114. Zhang S,He H,Day AJ,Tseng SC.Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex.J Biol Chem. 2012;287:12433-12444.
115. Zhuo L,Yamada M,Zhao M,Yingsung W,Yoshida N,Kitagawa Y,Kawamura K,Suzuki T,Kimata K.Defect in SHAP-hyaluronan complex causes severe female infertility: a study by inactivation of the bikunin gene in mice.J Biol Chem. 2001;276:7693-7696.